Sector ratings Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. Other stock markets 26/06/2026			5-day change	1st Jan Change
170.57 ^CHF	+1.62%		+14.99%	-

19/06	Charles River Laboratories International, Inc. and Eli Lilly and Company Enter Collaboration to Optimize Ai/Ml Platform Through Nonclinical Testing Expertise	CI
18/06	Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Visibility	Consensus
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	10.39B	-	AA
LONZA GROUP AG	46.2B		AAA
REVOLUTION MEDICINES, INC.	38.71B	-	B	-	-
IQVIA HOLDINGS INC.	31.9B		AAA
BEONE MEDICINES AG	31.12B		-
CELLTRION, INC.	23.77B		A
ASCENDIS PHARMA A/S	16.2B	-	-	-	-
MEDPACE HOLDINGS, INC.	15.05B		BBB
EUROFINS SCIENTIFIC SE	13.74B		AA
IONIS PHARMACEUTICALS, INC.	13.42B	-	A	-	-
ICON PUBLIC LIMITED COMPANY	13.01B		AAA
BIO-TECHNE CORPORATION	11.06B		AA
TEMPUS AI, INC.	10.08B		A		-
APOGEE THERAPEUTICS, INC.	9.93B	-	B	-	-
ALKERMES PLC	9.18B		A
PRAXIS PRECISION MEDICINES, INC.	9.14B	-	B	-	-
KYMERA THERAPEUTICS, INC.	8.89B	-	BBB	-	-
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-	-	-	-
QIAGEN N.V.	8.15B		AAA
IMMUNOVANT, INC.	7.98B	-	BB	-	-
Average	17.15B		A
Weighted average by Cap.			A